Fiducial Markers Market Size, Share and Growth Analysis with Leading participants - Boston Scientific Corporation, Naslund Medical AB, Carbon Medical Technologies and More

 

The Global Fiducial Markers Market stood at a value of USD 90.6 million in 2019 and is estimated to expand at a CAGR of 4.3% during the forecast period. At this growth rate, the market is likely to attain a value of USD 127.3 Million by the end of 2027, owing to increasing applications of radiation therapy across screening and treatments of deadly health conditions.

Fiducial markers are placed in the place with the help of endoscopes which makes them useful in the image-guided radiotherapy. The markers are sufficient for locating tumors and affected tissues. The use of markers helps to provide maximum radiation dosage to the targeted tissues. Thus, the fiducial markers are primarily used in the stereotactic radiosurgery for the treatment of deadly diseases. The demand for the radiosurgery is growing substantially from the past few years, which is driving growth of the global fiducial markers market.

To get a sample PDF copy of the report, visit @ https://www.reportsanddata.com/sample-enquiry-form/3471

In addition, the fiducial markers market is gaining traction substantially from past few years owing to an increase in the occurrence of few chronic diseases such as types of cancers, brain tumours, and Parkinson's diseases. According to CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States, the brain and other nervous system cancers were the 10th leading cause of death and could have claimed around 18,020 adults. In 2019, 24,000 adults in the U.S. underwent cancer and tumour screening processes. Additionally, cancer was the second foremost cause of death globally in 2018; raising awareness about benefits of early screening during treatments of cancers and other diseases have boosted the number of screenings and testing. This factor encouraged the adoption of radiosurgery coupled with a screening of diseases are estimated to boost the market growth in the coming years as well.

However, the higher cost involved in the restrain growth of the fiducial markers market. In addition, undeclared government reimbursement policies across several industries are restraining growth of the global fiducial markers market. Nonetheless, the demand for advanced radiosurgery and related instruments has encouraged robust investments for research and developments (R&D) for improving the existing systems. For instance, Veran Medical Technologies launched the SPiN System, which is new advanced navigation systems to be used during radiosurgery. Such recent advancements in the technologies are estimated to offer growth opportunities in the coming years.

The market in North America dominated the overall fiducial markers market in terms of market share and revenue in 2019. This growth of the market is attributed to robust investments for R&D, rising prevalence of all types of cancers, strong presence of key players in the region. Thanks to all these factors, adoption and advent of personalized medicine from the region have increased substantially and are estimated to grow in the coming years. Thus, the region is likely to exhibit growth with a lucrative CAGR of 3.9% by the end of the forthcoming period. However, the market in Europe held the second-largest share of overall fiducial markers market in 2019. This growth is recognized due to higher investment for adopting advanced healthcare in the region. Thus, the market is estimated to expand at a rate of 4.1% over the forecast period.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/fiducial-markers-market

Key participants in the fiducial markers market include:

Boston Scientific Corporation

Naslund Medical AB

Stellar Medical, Medtronic

Innovative Oncology Solutions

Nanovi A/S

Carbon Medical Technologies

CIVCO Radiotherapy

IZI Medical Products

Eckert & Ziegler

Fiducial Markers Market: Segmentation

For the purpose of this report, Reports And Data has segmented the Global Fiducial Markers Market based on type, modalities, application, end-user, and region:

Type Outlook (Revenue, USD Million; 2017-2027)

·       Metal-Based Markers

·       Polymer-Based Markers

·       Others

Modalities Outlook (Revenue, USD Million; 2017-2027)

·       Computed Tomography/Computer-Based Computed Tomography

·       Magnetic Resonance Imaging

·       Ultrasound

·       Radiotherapy

Application Outlook (Revenue, USD Million; 2017-2027)

·       Prostate cancer

·       Lung Cancer

·       Breast Cancer

·       Gastric Cancer

·       Others

End-User Outlook (Revenue, USD Million; 2017-2027)

·       Hospitals

·       Radiotherapy Centers

·       Academic & Research Centers

Regional Outlook (Revenue, USD Million; 2017-2027)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Benelux
• Rest of Europe
• Asia Pacific
• China
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East & Africa
• Saudi Arabia
• U.A.E.
• Rest of MEA 

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3471

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com